Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welpodcv 325
Welpodcv 325 is a potent antibiotic combination of Cefpodoxime and Potassium Clavulanate, designed to provide broad-spectrum antibacterial coverage against both Gram-positive and Gram-negative bacteria. This combination is particularly effective in overcoming antibiotic resistance, making it an ideal choice for treating various bacterial infections.
Uses of Welpodcv 325
Welpodcv 325 is indicated for the treatment of:
Respiratory tract infections (bronchitis, pneumonia, pharyngitis, tonsillitis)
Urinary tract infections (UTIs)
Skin and soft tissue infections
Otitis media and sinusitis
Gynecological infections
Bone and joint infections
Benefits of Welpodcv 325
Broad-Spectrum Antibacterial Action: Effective against multiple bacterial strains
Enhanced Efficacy Against Resistant Bacteria: Clavulanate prevents beta-lactamase inactivation
Rapid Symptom Relief: Reduces infection-related discomfort quickly
High Oral Bioavailability: Ensures effective systemic absorption
Clinically Proven & Well-Tolerated: Minimal gastrointestinal side effects
Mechanism of Action of Welpodcv 325
Cefpodoxime inhibits bacterial cell wall synthesis, leading to bacterial cell lysis and death.
Potassium Clavulanate inactivates beta-lactamase enzymes, protecting Cefpodoxime from bacterial resistance and enhancing its antibacterial activity.